Antidiabetics
Metformin + Glimepiride (500/2mg)
Tablet — 500mg/2mg
WHO-GMP
ANVISA
Product Overview
Fixed-dose combination for dual-mechanism glycemic control. Convenient single-tablet therapy improves compliance.
Indications
Type 2 diabetes mellitus not adequately controlled with monotherapy
Dosage Forms & Strength
Available Forms
Tablet
Strength
500mg/2mg
Regulatory Approvals
WHO-GMP
ANVISA